- 专利标题： Imidazopiperazinone inhibitors of transcription activating proteins
-
申请号： US16378309申请日： 2019-04-08
-
公开(公告)号： US10899769B2公开(公告)日： 2021-01-26
- 发明人: Kang Le , Michael J. Soth , Gang Liu , Philip Jones , Jason Bryant Cross , Timothy Joseph Mcafoos , Christopher L. Carroll , Richard T. Lewis
- 申请人： Board of Regents, The University of Texas System
- 申请人地址： US TX Austin
- 专利权人： Board of Regents, The University of Texas System
- 当前专利权人： Board of Regents, The University of Texas System
- 当前专利权人地址： US TX Austin
- 代理商 Dennis A. Bennett; Cynthia Hathaway; John Desper
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D519/00
摘要：
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.
公开/授权文献
信息查询
